REGULATED PRESS RELEASE published on 10/23/2024 at 17:40, 28 days 20 hours ago Eiffage wins in consortium the contract to extend and restructure the Henri Becquerel cancer treatment centre in Rouen (France) in a deal worth €72 million Eiffage, in consortium, wins €72 million contract to extend and restructure Henri Becquerel cancer treatment centre in Rouen, France, with innovative architectural design and environmental focus Eiffage Cancer Treatment Contract Henri Becquerel Rouen
BRIEF published on 10/17/2024 at 17:45, 1 month 3 days ago APRR's Q3 2024 Revenue and Traffic Analysis Credit Rating APRR Revenue Traffic Analysis Aliaé Growth Construction Revenue
REGULATED PRESS RELEASE published on 10/17/2024 at 17:40, 1 month 3 days ago APRR revenue and traffic for Q3 2024 APRR's Q3 2024 revenue increased by 3.9% to €2.4 billion. Traffic saw a 0.3% decrease year-on-year. Aliaé revenue surged by 12.4% Revenue APRR Aliaé Q3 2024 Traffic
BRIEF published on 10/02/2024 at 12:51, 1 month 19 days ago Monthly information on the share capital of Eiffage SA Share Capital Voting Rights AMF Eiffage SA Threshold Crossing
BRIEF published on 09/04/2024 at 17:55, 2 months 16 days ago Eiffage Begins Paris - SCOPE Renovation Project Eiffage Construction Renovation Environmental Paris - SCOPE
REGULATED PRESS RELEASE published on 09/04/2024 at 17:50, 2 months 16 days ago Eiffage starts work on the Paris - SCOPE renovation project Eiffage commences Paris - SCOPE renovation project involving structural overhaul, green certifications, and environmental sustainability measures Eiffage Renovation Paris - SCOPE Structural Overhaul Green Certifications
BRIEF published on 09/04/2024 at 16:56, 2 months 16 days ago EIFFAGE: Monthly information on voting rights and shares as of August 31, 2024 Eiffage Share Capital Voting Rights Actions Threshold Declaration
BRIEF published on 08/28/2024 at 17:45, 2 months 23 days ago 2024 Half-Year Results for Eiffage: Steady Growth in Revenue and Solid Earnings Performance Eiffage Revenue Growth Greenhouse Gas Emissions Order Book Half-year Results
REGULATED PRESS RELEASE published on 08/28/2024 at 17:40, 2 months 23 days ago 2024 half-year results Eiffage reports +6.3% revenue growth and solid earnings performance in 2024 first-half results, with positive outlook and sustainability commitments Eiffage Revenue Growth Sustainability Earnings Performance 2024 First-half Results
BRIEF published on 08/28/2024 at 08:35, 2 months 24 days ago SBTi Validates Eiffage’s Emission Reduction Targets for 2030 and 2050 Eiffage SBTi Emission Reduction Paris Agreement Net-zero 2050
Published on 11/21/2024 at 14:15, 21 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 36 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 36 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 36 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 20 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 21 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 2 hours 1 minute ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 16 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 51 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 51 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
